STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (OTC:OCS) announced a notification of a managers' transaction relating to the vesting and settlement of restricted stock units (RSUs) previously granted to a company director.

The notification names Arshad Khanani and cites an RSU vesting event dated 25 November 2025. No financial amounts or additional transactions were disclosed.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ZUG, Switzerland, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company.

Attachment


FAQ

What did Oculis (OCS) disclose about the RSU vesting on 25 November 2025?

Oculis disclosed a notification that RSUs previously granted to director Arshad Khanani vested and were settled on 25 November 2025.

Will the RSU vesting for Arshad Khanani trigger an SEC Form 4 or equivalent filing for OCS?

The company published a managers' transaction notification, which typically accompanies required insider filings for RSU vesting; check regulatory filings for the formal Form 4 or local equivalent.

Does the Oculis (OCS) notice specify the number of shares or cash value from the RSU settlement?

No; the notification names the director and the vesting date but does not disclose the number of shares or monetary amounts.

How might the RSU vesting for Arshad Khanani affect Oculis (OCS) shareholders?

The notice reports a standard insider compensation event; the company did not disclose amounts, so direct shareholder impact is not specified.

Where can investors find the full details of the Oculis (OCS) managers' transaction notification?

Investors should consult Oculis investor relations and official regulatory filings around the 25 November 2025 notification for the full disclosure.

Was the RSU vesting for Oculis (OCS) described as a new grant or settlement of previously granted RSUs?

The notification describes the event as the vesting and settlement of RSUs previously granted, not a new grant.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.09B
48.60M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug